Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pfeffer

Showing results (481-490 of 908) with videos related to

Pageof 91
Sort By:
Circulation|December 1, 2004
Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) studyMariya P Tokmakova, Hicham Skali, Satish Kenchaiah, et al.
Kardiologiia|January 1, 1993
[Effect of captopril on mortality and morbidity in patients with dysfunction of the left ventricle after myocardial infarction. Results on survival and hypertrophic studies]M A Pfeffer, Iu Braunvald, L A Moĭe, et al.
Lancet (London, England)|September 1, 2000
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trialJ L Rouleau, M A Pfeffer, D J Stewart, et al.
Circulation|November 24, 1999
Randomized trial of partial versus complete chordal preservation methods of mitral valve replacement: A preliminary reportK L Yun, C F Sintek, D C Miller, et al.
Journal of the American College of Cardiology|May 12, 2012
Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) programDavide Castagno, Hicham Skali, Madoka Takeuchi, et al.
European Journal of Heart Failure|September 29, 2005
Pulsatile hemodynamic effects of candesartan in patients with chronic heart failure: the CHARM ProgramGary F Mitchell, J Malcolm O Arnold, Mark E Dunlap, et al.
Open Forum Infectious Diseases|January 10, 2022
Lower Severe Acute Respiratory Syndrome Coronavirus 2 Viral Shedding Following Coronavirus Disease 2019 Vaccination Among Healthcare Workers in Los Angeles, CaliforniaPaul C Adamson, Michael A Pfeffer, Valerie A Arboleda, et al.
European Journal of Heart Failure|March 1, 2014
Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRTHicham Skali, Edward M Dwyer, Robert Goldstein, et al.
Circulation Research|May 1, 1984
Renal and systemic hemodynamic responses to intravenous infusion of leukotriene C4 in the ratK F Badr, C Baylis, J M Pfeffer, et al.
The American Journal of Cardiology|March 25, 2008
Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitusNagesh S Anavekar, Scott D Solomon, John J V McMurray, et al.
Pageof 91

Showing results (481-490 of 908) with videos related to

Sort By:
Pageof 91
Circulation|December 1, 2004
Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) studyMariya P Tokmakova, Hicham Skali, Satish Kenchaiah, et al.
Kardiologiia|January 1, 1993
[Effect of captopril on mortality and morbidity in patients with dysfunction of the left ventricle after myocardial infarction. Results on survival and hypertrophic studies]M A Pfeffer, Iu Braunvald, L A Moĭe, et al.
Lancet (London, England)|September 1, 2000
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trialJ L Rouleau, M A Pfeffer, D J Stewart, et al.
Circulation|November 24, 1999
Randomized trial of partial versus complete chordal preservation methods of mitral valve replacement: A preliminary reportK L Yun, C F Sintek, D C Miller, et al.
Journal of the American College of Cardiology|May 12, 2012
Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) programDavide Castagno, Hicham Skali, Madoka Takeuchi, et al.
European Journal of Heart Failure|September 29, 2005
Pulsatile hemodynamic effects of candesartan in patients with chronic heart failure: the CHARM ProgramGary F Mitchell, J Malcolm O Arnold, Mark E Dunlap, et al.
Open Forum Infectious Diseases|January 10, 2022
Lower Severe Acute Respiratory Syndrome Coronavirus 2 Viral Shedding Following Coronavirus Disease 2019 Vaccination Among Healthcare Workers in Los Angeles, CaliforniaPaul C Adamson, Michael A Pfeffer, Valerie A Arboleda, et al.
European Journal of Heart Failure|March 1, 2014
Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRTHicham Skali, Edward M Dwyer, Robert Goldstein, et al.
Circulation Research|May 1, 1984
Renal and systemic hemodynamic responses to intravenous infusion of leukotriene C4 in the ratK F Badr, C Baylis, J M Pfeffer, et al.
The American Journal of Cardiology|March 25, 2008
Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitusNagesh S Anavekar, Scott D Solomon, John J V McMurray, et al.
Pageof 91